Project Details
Description
An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. coli-derived Asparaginases
| Status | Finished |
|---|---|
| Effective start/end date | 6/11/20 → 5/31/23 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- JAZZ PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.